Jim Mellon is a British entrepreneur, investor and philanthropist with a wide range of interests. Through his private investment company, Burnbrae Group, he has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies.
Jim holds a master’s degree in Politics, Philosophy and Economics from the University of Oxford and, since graduating in 1978, his entire career has been spent in asset management. He spent his early career specialising in emerging markets before becoming a major investor in a broad range of sectors including property, natural resources and biotechnology. Jim is a director and major shareholder of several companies including – Chairman of Manx Financial Group, controlling shareholder and Chairman of Endurance RP Group, a Hong Kong-based investment company which focuses on the healthcare and late-stage life sciences sectors, and co-founded Juvenescence, a company developing therapies for longevity and Agronomics to invest in a portfolio of leading companies in the field of cellular agriculture.
A noted author, Mr. Mellon has written several books, most recently Moo’s Law, focusing on investment opportunities in the field of cellular agriculture – the production of proteins and materials directly from cells. His other titles include Juvenescence: Investing in the Age of Longevity and Wake Up! Survive and Prosper in the Coming Economic Turmoil, which predicted the economic downturn of 2007 and 2008.
Jim sits on the Board of Trustees of the Buck Institute for Research on Aging, and of the American Federation for Aging Research (AFAR). He is an Honorary Fellow of Oriel College at the University of Oxford, where he has established the Mellon Centre for Longevity, and he also sits on the Advisory Board of the Milken Institute’s Centre for the Future of Aging.
